20S Proteasome β5 Inhibitors

The chemical class of 20S Proteasome β5 inhibitors encompasses a range of compounds that specifically target the β5 subunit of the 20S proteasome, a proteolytic complex crucial for degrading ubiquitinated proteins within cells. These inhibitors play a pivotal role in modulating the proteasome's activity, thereby influencing various cellular processes including cell cycle regulation, apoptosis, and signaling pathway regulation. Compounds such as Bortezomib, Carfilzomib, and MG-132 are characterized by their ability to bind to the catalytic site of the 20S proteasome β5 subunit, inhibiting its chymotrypsin-like activity. This inhibition results in the accumulation of poly-ubiquitinated proteins, which can lead to cellular stress and affect a multitude of cellular signaling pathways. Bortezomib, for instance, is a reversible inhibitor, allowing for transient modulation of proteasome activity, while Carfilzomib forms an irreversible bond, leading to sustained inhibition.

Lactacystin, another proteasome inhibitor, uniquely forms an irreversible bond with the active site of the β5 subunit. This action impedes the degradation of regulatory proteins, affecting various cellular pathways. Oprozomib and Marizomib, both potent inhibitors, similarly bind to the β5 subunit, impacting cell survival and proliferation. Delanzomib and Ixazomib, through selective inhibition of the β5 subunit, also contribute to the build-up of ubiquitinated proteins, influencing cell signaling and survival. Salinosporamide A (NPI-0052) and Epoxomicin are known for their potent and irreversible inhibition of the proteasome β5 subunit. They affect protein degradation pathways, with consequential impacts on cell cycle regulation. PR-171, a precursor to Carfilzomib, shares a similar mechanism, targeting the β5 subunit and influencing cell survival pathways. Lastly, CEP-18770, a dipeptidyl boronic acid derivative, selectively inhibits the chymotrypsin-like activity of the β5 subunit, affecting protein turnover and disrupting cellular signaling pathways. In summary, 20S Proteasome β5 inhibitors are a diverse group of chemicals that modulate the proteolytic activity of the 20S proteasome.